Preoperative combination chemotherapy with S-1 and low dose cisplatin against highly advanced gastric carcinoma

被引:2
作者
Saikawa, Y
Akasaka, Y
Kanai, T
Otani, Y
Kumai, K
Kubota, T
Kitajima, M
机构
[1] Keio Univ, Dept Surg, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan
[2] Toho Univ, Sch Med, Dept Pathol 2, Ohta Ku, Tokyo 1438540, Japan
[3] Hiratsuka City Hosp, Dept Surg, Hiratsuka, Kanagawa 2540065, Japan
关键词
preoperative chemotherapy; gastric cancer; S-1; cisplatin;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We performed preoperative chemotherapy with S-1 and low-dose CDDP (TSLD) to treat 9 patients of highly advanced gastric cancer. Five cases showed significant effect with severe fibrosis diagnosed as grade 1b-2 effect in histology, and all 9 cases showed at least grade la effect in either primary lesion or lymph node. While toxicity of less than grade 3 (gastrointestinal disorder and/or bone marrow suppression) were observed in 5 out of 9 cases (55.6%), no symptom was observed in 3 out of the 5 patients. We conclude that the TSLD is useful to control highly advanced gastric cancer.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 18 条
[1]  
Chung YS, 1997, CANCER, V80, P1
[2]  
*DCTD DHHS NCI NIH, 1998, OFF REF CTC VERS 2 0
[3]   Phase II trial of outpatient schedule of paclitaxel in patients with previously untreated metastatic, measurable adenocarcinoma of the stomach [J].
Garcia, AA ;
Leichman, CG ;
Lenz, HJ ;
Baranda, J ;
Lujan, R ;
Casagrande, Y ;
Leichman, L .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (06) :275-278
[4]  
HARRIS BE, 1990, CANCER RES, V50, P197
[5]  
Hundahl SA, 2000, CANCER-AM CANCER SOC, V88, P921, DOI 10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.3.CO
[6]  
2-J
[7]   Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: Report of a case [J].
Iwahashi, M ;
Nakamori, M ;
Tani, M ;
Yamaue, H ;
Sakaguchi, S ;
Nakamura, M ;
Ueda, K ;
Ichiro, M ;
Nishino, E ;
Tanimura, H .
ONCOLOGY, 2001, 61 (01) :16-22
[8]  
*JAP RES SOC GASTR, 2001, JAP CLASS GASTR CARC
[9]   PATTERNS OF FAILURE FOLLOWING CURATIVE RESECTION OF GASTRIC-CARCINOMA [J].
LANDRY, J ;
TEPPER, JE ;
WOOD, WC ;
MOULTON, EO ;
KOERNER, F ;
SULLINGER, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 19 (06) :1357-1362
[10]   Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. [J].
Macdonald, JS ;
Smalley, SR ;
Benedetti, J ;
Hundahl, SA ;
Estes, NC ;
Stemmermann, GN ;
Haller, DG ;
Ajani, JA ;
Gunderson, LL ;
Jessup, JM ;
Martenson, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (10) :725-730